Caredx appoints bryan riggsbee to its board of directors

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) — the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that bryan riggsbee joins caredx's board of directors, effective march 11, 2024. “we're pleased to welcome bryan to our board,” said michael goldberg, caredx board chairperson. “his financial.
CDNA Ratings Summary
CDNA Quant Ranking